Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In the USA, the burden of hepatitis B disproportionately affects high-risk adults who alone account for more than 75% of newly reported hepatitis B virus infections each year. Despite the localization of new infections in identifiable high-risk groups, vaccination rates in this subgroup, with the exception of health care workers, remain consistently low. The purpose of this study was to characterize those at risk for hepatitis B transmission and quantify the association between missed opportunities and hepatitis B vaccination.
Data from the 2007 Behavioral Risk Factor Surveillance Survey (BRFSS) of adults aged 18 years and older who were at high risk for hepatitis B infection (n = 15,432) were analyzed. Multivariate regression analysis was conducted to determine factors independently associated with vaccination.
In a nationally representative sample, 51.4% of high-risk adults remained unvaccinated against hepatitis B and more than 50% had a missed opportunity for vaccination. High-risk adults who were vaccinated against pneumonia and influenza had a higher odds ratio of being vaccinated against hepatitis B than those not vaccinated against pneumonia and influenza (OR 2.27 and 1.67, respectively). Also, high-risk adults tested for human immunodeficiency virus (HIV) at a counseling and testing site or a drug treatment facility had a higher OR of being vaccinated than those who had not been tested for HIV (OR 1.78 and 1.73, respectively). The opposite relationship was true among individuals tested for HIV at a correctional facility (OR 0.60).
The findings of this study underscore the inadequacy of vaccination coverage in high-risk adults and highlight advantageous opportunities to bridge gaps in vaccination coverage.
- Centers for Disease Control and Prevention: Disease burden from viral hepatitis A, B, and C in the United States. Available at:http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/disease_burden2002.pdf. Accessed 27 Nov 2010.
- Rich JD, Ching CG, Lally MA, Gaitanis MM, Schwartzapfel B, Charuvastra A, Beckwith CG, Flanigan TP. A review of the case for hepatitis B vaccination of high risk adults. Am J Med. 2003;114:316–8. CrossRef
- Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations from the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR 2006;55:1–25. http://www.cdc.gov/mmwr/pdf/rr/rr5516.pdf.
- Wasley A, Moran DK, Kuhnert W, Simard EP, Finelli L, McQuillan G, Bell B. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis. 2010;202:192–201. CrossRef
- Ndiaye SM, Hopkins DP, Shefer AM, Hinman AR, Briss PA, Rodewald L, Willis B. Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high risk adults. Am J Prev Med. 2005;28:248–79. CrossRef
- Nidhi J, Yusuf H, Wortley PM, Euler GL, Walton S, Stokley S. Factors associated with receiving the hepatitis B vaccination among high-risk adults in the United States: an analysis of the national health interview survey, 2000. Fam Med. 2004;36:480–6.
- Mackeller DA, Valleroy LA, Secura GM, et al. Two decades after the vaccine license: hepatitis B immunization and infection among young men who have sex with men. Am J Public Health. 2001;91:965–71. CrossRef
- Center for Disease Control and Prevention. Achievements in public health: hepatitis B vaccination—United States, 1982–2002. MMWR Morb Mortal Wkl Rep 2002;51:549–53, 563.
- Centers for Disease Control and Prevention. Hepatitis B vaccination among high-risk adolescents and adults—San Diego, California, 1998–2001. MMWR Morb Mortal Wkl Rep. 2002;51:618–21.
- IOM (Institute of Medicine). Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. The National Academies Press, Washington, DC; 2010.
- Centers for Disease Control and Prevention (CDC). Improving influenza, pneumococcal polysaccharide and hepatitis B vaccination coverage among adults <65 years at high risk: a report on recommendations of the task force on community preventative services. MMWR 2005;54(RR-5).
- Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system survey questionnaire. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta; 2007.
- Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system survey data. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta; 2007.
- Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G, et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J Infect Dis. 2000;181:413–8. CrossRef
- Agladioglu S, Beyazova U, Camurdan AD, Sahin F, Atak A. Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules. Infection. 2010;38:269–73. CrossRef
- Centers for Disease Control and Prevention. Hepatitis B vaccination coverage among adults–United States 2004. MMWR 2006;55:509–511. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5518a3.htm
- StataCorp. Stata statistical software: release 10. StatCorp, College Station; 2007.
- Owens GM. Gender differences in health care expenditure, resource utilization and quality of care. J Manag Care Pharm. 2008;14:S2–6.
- Joung MA, Vander der Meer JB, Mackenback JP. Marital status and health care utilization. Int J Epidemiol. 1994;24:569–75. CrossRef
- Bevier P, Chamont E, Gallachi MB, Loutan L. Importance of patient’s perceptions and general practitioner’s recommendations in understanding missed opportunities for immunizations in Swiss adults. Vaccine. 2001;19:4760–7. CrossRef
- Orenstein WA, Mootrey GT, Pazol K, Hinman AR. Financing immunization of adults in the United States. Clin Pharmacol Ther. 2007;82:764–8. CrossRef
- Hinman AR, Orenstein WA. Adult immunization: what can we learn from the childhood immunization program? Clin Infect Dis. 2007;44:1532–5. CrossRef
- Hepatitis B Foundation. Hepatitis B vaccination. Available at: http://www.hepb.org/hepb/vaccine_information.htm. Accessed 10 May 2010.
- Rosenbaum S, Stewart A, Cox M, Lee A. Medicaid coverage of immunization in non-institutionalized adults. Center for Health Services Research and Policy, George Washington University, Washington, DC; 2003. Available at: http://www.gwumc.edu/sphhs/departments/healthpolicy/CHPR/downloads/Medicaid_Immunization_Study.pdf. Accessed 27 Feb 2011.
- Daley MF, Henessey KA, Weinbaum CM, Stockley S, Hurly LP, Crane LA, et al. Physician practices regarding adult hepatitis B vaccination. Am J Prev Med. 2009;36:491–6. CrossRef
- Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PC, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–65. CrossRef
- Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007
Volume 40, Issue 4 , pp 405-413
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Hepatitis B virus
- High-risk adults
- Missed opportunities
- Industry Sectors
- Author Affiliations
- 1. Program in Public Health, Division of Biomedicine, Brown University, 121 South Main Street, Box G, Providence, RI, 02903, USA
- 6. 72 Orchard Avenue, Barrington, RI, 02806, USA
- 2. Program in Public Health, Center for Population Health and Clinical Epidemiology, Brown University, 121 South Main St. S121-2, Providence, RI, 02912, USA
- 3. Warren Alpert Medical School, Brown University, Box G-S121, 121 South Main Street, Providence, RI, 02912, USA
- 4. Division of Biomedicine, Brown University, 121 South Main Street, Box G, Providence, RI, 02903, USA
- 5. Infectious Diseases, Brown University/Miriam Hospital, 164 Summit Ave, Providence, RI, 02906, USA